All Industries

Giving Traders What They Want: The Trading Pit Adds NinjaTrader Integration

Benzinga

By Meg Flippin, Benzinga When it comes to trading, speed is of the essence. To be successful, traders need access to fast trading platforms, customizable tools and deep insights into market moves. The Trading Pit, a proprietary trading firm, knows that – which is why it just added integration with NinjaTrader to its arsenal of trading platforms. It makes sense that The Trading Pit would integrate with the NinjaTrader platform. After all, NinjaTrader has a reputation in the market for its speed, efficiency and customizable features, reports The Trading Pit. NinjaTrader is also something the trading firm says customers were clamoring for, and since it’s committed to giving its prop traders what they want, integration with NinjaTrader was a no-brainer. “Traders have shown great enthusiasm for the NinjaTrader platform, renowned for its speed, efficiency and customizable features,” wrote The Trading Pit when announcing the integration. “At The Trading Pit, we’ve always prioritized listening to our community, and this integration is a clear reflection of that commitment. By offering NinjaTrader with its Prime Futures challenges, The Trading Pit provides prop traders with the precision and control needed to excel in the competitive futures market.” The Trading Pit is committed to meeting the demands of its traders. To learn more about its offering, click here. Empowering Traders With Platforms And Tools Liechtenstein-based The Trading Pit, with offices in Spain and Cyprus, is a proprietary trading firm that offers traders the chance to hone their skills on cutting-edge simulated platforms. The firm says it empowers traders to enhance their strategies while earning up to 80% of their simulated profits. The Trading Pit offers a diverse range of trading challenges aimed at cultivating and identifying trading talent. To achieve that, the company offers comprehensive support, including educational resources, mentorship and personalized tools. What The Trading Pit says sets NinjaTrader apart from its rivals is its advanced functionalities that enable futures traders to execute strategies with accuracy and precision, tailor trading environments to individual preferences and gain deeper insights into market movements. Combine that with The Trading Pit’s other integrations, including Tradovate, which is a commission-free futures trading platform and TradingView, which provides charting and analysis tools, and The Trading Pit says it marks the beginning of a new chapter for the trading firm. One in which innovation meets trader-focused solutions. "In addition to NinjaTrader, traders will enjoy seamless access to the Tradovate Trading platform, all with the same user account," added Daniela Egli, CEO of The Trading Pit. "We are also pleased to offer the TradingView add-on for free to all our customers, enhancing their analytical capabilities at no extra cost." The Futures Market Growth Trajectory The Trading Pit’s commitment to offering traders access to robust platforms and tools to test out their strategies comes as the futures market continues its long-term growth trajectory. Last year the total volume of trading reached 137.3 billion contracts, up 64% year-over-year. It marked the sixth year in a row in which trading activity in the global listed derivatives market set a record. The Asia-Pacific region saw the largest increase, followed by North America, Latin America and Europe. The integration of NinjaTrader also supports The Trading Pit’s efforts to expand into new markets, including the U.K., Canada and the U.S., places NinjaTrader has a strong following, reports The Trading Pit. The collaboration aims to attract futures traders and members of the NinjaTrader community, offering them what the company says is an enhanced trading experience and funded accounts. Proprietary trading firms use their own money to make trades, so it behooves them to find talented traders and provide top-notch support so everyone can thrive. The Trading Pit is betting its integration with NinjaTrader, coupled with Tradovate and TradingView achieves that. To learn more about how The Trading Pit empowers its traders, click here. Featured photo courtesy of The Trading Pit. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

November 06, 2024 08:35 AM Eastern Standard Time

Image

Air Voel Expands Product Line with the Latest ResMed CPAP Machines for Enhanced Sleep Therapy

Rev Up Marketers

Air Voel, a leading provider of CPAP solutions in Canada, is proud to announce the expansion of its product line with the latest CPAP machines from ResMed. Known for its dedication to improving sleep health through quality CPAP equipment and personalized service, Air Voel now offers the newest ResMed models, which are designed to provide enhanced comfort, cutting-edge technology, and optimal therapy for individuals with sleep apnea. With this expanded selection, Air Voel continues to solidify its role as a trusted source for CPAP machines, CPAP masks Canada, and accessories across Canada. Located at 4195 Dundas St W, Unit 6, Toronto, ON M8X 1Y4, Air Voel is committed to delivering top-tier CPAP solutions, offering Canadian customers access to the most recent advancements in sleep therapy. The newly available ResMed models are crafted to deliver superior performance, quiet operation, and user-friendly interfaces, all of which are crucial for effective and comfortable sleep apnea treatment. Enhanced Features and Comfort with the Latest ResMed CPAP Machines ResMed has long been recognized for its high-quality sleep therapy devices, and the latest models embody the brand’s commitment to innovation and patient comfort. New offerings at Air Voel include the ResMed AirSense 11 AutoSet and the ResMed AirMini Travel CPAP. These devices incorporate ResMed’s advanced AutoSet technology, which adjusts pressure settings in real-time according to the user’s breathing patterns. This feature helps ensure that patients receive just the right amount of air pressure throughout the night, promoting restful sleep and improving therapy adherence. The AirSense 11, known for its quiet operation and intuitive touchscreen, offers users a seamless therapy experience with integrated humidification to prevent dryness and discomfort. Meanwhile, the AirMini, as a compact and travel-friendly option, provides all the functionality of a full-sized CPAP machine in a portable design, making it ideal for patients who require therapy on the go. With these advanced ResMed models now available, Air Voel provides its customers with greater flexibility in selecting the device that best suits their lifestyle and therapeutic needs. Commitment to Customer Care and Education AirVoel’s expansion of its ResMed product line underscores the company’s commitment to offering not only the best products but also comprehensive support and guidance. The team provides personalized consultations to assist with device selection, mask fitting, and device settings, ensuring that each customer maximizes the benefits of their CPAP therapy. “Our goal is to improve our customers’ quality of life by offering the most advanced and reliable CPAP solutions,” says Roman Korytski, founder of Air Voel. “With the latest ResMed machines, we are giving patients even more options for effective, comfortable, and convenient sleep therapy.” Visit Air Voel Today for the Latest ResMed CPAP Solutions For those interested in exploring Air Voel’s newly expanded line of ResMed CPAP machines, visit the store at AirVoel.ca or browse their CPAP Machines collection. Contact Details Air Voel Roman Korytski +1 844-688-2727 george.anderson138@gmail.com Company Website https://airvoel.ca/

November 06, 2024 06:41 AM Eastern Standard Time

Image

Nift Networks CEO Reveals Innovative Customer Acquisition Strategy for Shopify Merchants on eCommerce Fastlane Podcast

eCommerceFastlane

FOR IMMEDIATE RELEASE In a recent episode of eCommerce Fastlane, host Steve Hutt welcomed Elery Pfeffer, CEO and Founder of Nift Networks, to discuss revolutionary approaches to customer acquisition for Shopify merchants. The episode unveiled how Nift's gifting platform transforms traditional advertising models by connecting brands with consumers through a unique closed ecosystem of premium consumer apps. Unlike conventional advertising channels, Pfeffer shared insights on how their platform maintains consistent return on ad spend (ROAS) during peak seasons. A highlight of the discussion was Blenders Eyewear's success story. Through Nift's platform, the company achieved a remarkable 545% increase in customer growth during Q4. This case study demonstrated the platform's ability to drive sales even during traditionally slow seasons. "The way brands think about us is if they spend $40 to acquire every net new customer on Meta, they should think about giving most of that value to the consumer on Nift," explained Pfeffer. The episode also addressed critical topics including: - First-party data collection and privacy protection - Integration capabilities with Shopify and Klaviyo - Strategic customer matching using AI technology - Cost-effective customer acquisition strategies For Shopify merchants spending over $1 million annually on advertising, Nift offers an exclusive promotion of $1,000 in ad credits for new sign-ups before year-end. The full episode is available on all major podcast platforms and at https://ecommercefastlane.com/podcast/episode-369 Contact Details Steve Hutt steve@ecommercefastlane.com Company Website https://ecommercefastlane.com

November 05, 2024 04:04 PM Eastern Standard Time

Stars of Paddington Bear film invite you to explore Peru

Promperu

Actors of the successful Paddington movie series gathered in London on Sunday for the world premiere of its latest installment. Directed by Dougal Wilson, the 2024 film “Paddington in Peru” will spark the interest and tourism in Peru across the world, featuring internationally renowned bucket-list attractions. World-famous Hugh Bonneville, who plays Henry Brown in the series of beloved family films, addressed the Peruvian audience: “Thank you for loaning us your spectacled bear who has brought such joy to our nation and hopefully you are now getting an influx of tourists coming to visit you”. Hollywood A-list star Antonio Banderas plays riverboat captain Hunter Cabot, who assists the Brown family on their adventure. The actor spoke of his memories in Paddington’s homeland and noted, “I visited Peru with my daughter Stella six years ago, we did the Inka Trail, walking from Cusco to Machupicchu. We did it in four days. It wasn’t easy but it was one of the most beautiful and spiritual experiences that I had in my life”. The ursine hero from "deepest, darkest Peru" first appeared in UK author Michael Bond's 1958 book "A Bear Called Paddington". "Paddington in Peru" opens in the UK and Ireland on November 8, and in the US early in 2025. FILM IN PERU PROMPERÚ's strategy to promote the country as a filming location, provided assistance for filming in Lima and Cusco, coordinating with public and private entities to secure permits and visas for Paddington film crew. For more information about this service visit www.filminperu.com Peru Export and Tourism Promotion Board (PROMPERÚ). We are the government agency in charge of the development and implementation of global strategies to position Peru via the promotion of its image, touristic destinations, added value exports and inversions. Contact Details José Carlos Collazos jcollazos@promperu.gob.pe Company Website http://www.promperu.gob.pe

November 05, 2024 03:57 PM Eastern Standard Time

Image

Copper Property CTL Pass Through Trust Schedules Live Call to Discuss Recent Financial and Operating Results

Copper Property CTL Pass Through Trust

Copper Property CTL Pass Through Trust (“the Trust”) announced today that it will host a live conference call on Tuesday, November 12, 2024 at 12:00 pm Eastern Time. Members of the Trust’s management team will discuss its recent financial and operating results as reflected in the Trust’s monthly report for the period ended October 31, 2024, and Form 10-Q for the period ended September 30, 2024, both of which are expected to be filed prior to the call. The conference call will include a question and answer (Q&A) session. Conference Call Details: DATE: Tuesday, November 12, 2024 TIME: 11:00 am CDT | 12:00 pm EDT DIAL-IN: U.S. & Canada Toll Free: (877) 841-2983 or International (215) 268-9893 WEBCAST: www.ctltrust.net via the Investor Relations Section or click here to access REPLAY (Available for 30 days): U.S. & Canada Toll Free: (877) 660-6853 / International: (201) 612-7415 Conference ID#: 13750090 Telephone Replays will be made available approximately 3 hours after the conference end time. Participants will be required to state their name and company upon accessing the replay. Additional information, including the Trust’s Monthly and Quarterly Reports, as well as other filings with the Securities and Exchange Commission (“SEC”) can be accessed via the Trust’s website at www.ctltrust.net. About Copper Property CTL Pass Through Trust Copper Property CTL Pass Through Trust (the “Trust”) was established to acquire 160 retail properties and 6 warehouse distribution centers (the “Properties”) from J.C. Penney as part of its Chapter 11 plan of reorganization. The Trust’s operations consist solely of owning, leasing and selling the Properties. The Trust’s objective is to sell the Properties to third-party purchasers as promptly as practicable. The Trustee of the trust is GLAS Trust Company LLC. The Trust is externally managed by an affiliate of Hilco Real Estate LLC. The Trust is intended to be treated, for tax purposes, as a liquidating trust within the meaning of United States Treasury Regulation Section 301.7701-4(d). For more information, please visit https://www.ctltrust.net/. Forward Looking Statement This news release contains certain “forward-looking statements”. All statements other than statements of historical fact are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward looking terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “our vision,” “plan,” “potential,” “preliminary,” “predict,” “should,” “will,” or “would” or the negative thereof or other variations thereof or comparable terminology and include, but are not limited to, the Trust’s expectations or beliefs concerning future events and stock price performance. The Trust has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While the Trust believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond its control. These factors, including those discussed in the Trust’s Registration Statement on Form 10 filed with the Securities and Exchange Commission (the “SEC”), may cause its actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. For a further list and description of such risks and uncertainties, please refer to the Trust’s filings with the SEC that are available at www.sec.gov. The Trust cautions you that the list of important factors included in the Trust’s SEC filings may not contain all of the material factors that are important to you. In addition, in light of these risks and uncertainties, the matters referred to in the forward-looking statements contained in this news release may not in fact occur. The Trust undertakes no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law. Contact Details Jessica Cummins +1 847-313-4755 jcummins@hilcoglobal.com Company Website https://ctltrust.net/about/default.aspx

November 05, 2024 01:46 PM Eastern Standard Time

News Release

The Money Service Lab announces the launch of its licenced service model for Issuers globally

BNP Paribas SA

The Money Service Lab (MSL) today announced the launch of its licencing model for entities wishing to become their own issuing processor for Visa, MasterCard, Discover and other card scheme networks. The move comes after the company successfully completed its MasterCard Europe certification, alongside Visa LAC and other ongoing certifications. Europe alone has circa 5,000 banks in situ and globally the number is closer to 40,000 whilst there are less than 50 processors operating at any scale. The European Central Bank estimated that there were over 72 billion card transactions processed in Europe in 2023. Lee Britton, Strategy Director at MSL said “When we founded the Money Service Lab in 2021 our vision was based on 2 factors; a huge increase in card-based transactions, whether physical or digital and a gap in the market for banks and issuers to become their own processor, instead of relying on the old incumbents. We set about creating a platform that could cater for three scenarios, the first being the old established ‘Managed Processing as a service’, where MSL would run the platform on behalf of our clients and do everything, from soup to nuts. The second scenario we envisaged was where MSL would still be the certified processor but our clients would run the platform on a day-to-day basis, configuring programmes, changes, fees, limits, spend control functions and multi-currency capabilities for example. But the third scenario we planned for and built, and the one that really interested us the most, was where we could licence or sell the platform to banks, credit card issuers, eMoney institutions, tech companies and integrators, where they would become the certified processor in their own right with access to the source code and ability to customise and change as they wished”. Mike Muscato, CTO for Money Service Lab, stated “What intrigued us at the beginning of the journey was ‘how do we empower more banks and issuers generally to take control of the card systems they rely on and enable them to launch portfolios on their own version of the platform’. We knew it would be a challenge and we had a lot of head-scratching moments in 2022 to figure out how to create multiple instances of the platform, almost at the drop of a hat and to maintain all the functionality available in our platform consistently through our licencing model, without compromising on our enormous processing power and ability to throttle and process circa 9000 Transactions Per Second (9000 TPS). Luckily, we had huge experience of this in our sister company, Muscato Corporation where we licence our switch, ENGIN© to many of the world’s largest processors, in Healthcare and Financial systems as examples. We estimate that around 15% of all financial transactions in the USA pass through ENGIN© through our licence customers, so it was a no-brainer for us at MSL to put ENGIN© at the heart of our platform” Mike Muscato went on to say “So as we perfected the MSL platform we took a leaf out of the Muscato Corporation playbook and took the same licencing approach, so if you are licencing the MSL platform you are getting also the best of the ENGIN© switch as well, tried and tested by some of the world’s largest financial processors. Conor Doyle, CEO of MSL, said ‘With card-based transactions increasing year-on-year at around 15% it is a clearly a fast-growing market, accelerating at a rapid pace. Our belief is that there are too few processors and globally there are just a handful present in every region, mostly managing legacy technical stacks. That gap in the market is where a company like MSL can make a difference. Multi-Currency processing is standard for us, alongside spend controls, fraud and risk monitoring and our pretty much unique ‘Compliance as a Service’ risk and AML system which provides the issuer or technology partner with everything needed to be able to control and report suspicious activity to their own regulator, as well as complementing their own internal systems. My belief, having been around processors since the early 2000’s, is that we have built something that we can grow globally but we can put the power back into the hands of the banks, credit card issuers and eMoney and Payment Institutions, so that they can process their own cards at a fraction of the cost they pay externally today. Combine that with the ability to move between any one of the three model (managed, hybrid or licenced) as well as the fact we are more than happy to sell the platform as an instance and pass over the source code, makes it, in my view, a pretty compelling proposition’. About MSL Payments Headquartered in London, United Kingdom, with offices in USA and Spain, MSL provides an innovative payment solutions platform for banks, credit card issuers, eMoney and Payment Institutions and programmes and programme managers. Currently already certified in Europe and Latin America Caribbean, MSL will continue to obtain certifications globally to help businesses all over the world create awesome customer experiences. MSL offers a full range of services, including issuing processing either as managed service or as a licence (where the client becomes the processor) as well as market-leading programme management and highly skilled payments expertise to create customisable feature-rich solutions for issuers, businesses, brands and their customers. About Muscato Corporation Specializing in developing, marketing and implementing transaction technologies for both established and emerging markets and creating outlets for licensing and operating its solution sets. Muscato has a firmed foundation in several vertical markets, including healthcare and financial payments, with significant financial and operational impact to the overall organization. With over 35 year track record of architecting, developing and implementing highly scalable transaction processing software, managing tens of billions of transactions yearly, Muscato is widely recognized in performance engineering and delivery systems. Muscato has a worldwide footprint through our suite of products. Products define the next generation of e-commerce platforms, specifically message brokering, card management, fully integrated healthcare payer exchange, money remittance, mobile banking, and transaction security. For MSL Payments Come and explore the many opportunities our platform has to offer by visiting us at www.themsl.com or email us on info@themsl.com For Muscato Corporation For all enquiries, please reach out to Muscato Corporation at sales@muscato.com or visit us at www.muscato.com/ News Source: PinionNewswire Contact Details Muscato Corporation sales@muscato.com Company Website https://csj-consulting.com/

November 05, 2024 09:01 AM Eastern Standard Time

With Milei's Economic Reforms, Gaucho Holdings Eyes Growth In Argentina's Markets

Benzinga

By Anthony Termini, Benzinga In December 2023, Argentina elected Javier Milei to the presidency after he pledged fiscal balance, zero budget deficits, and pro-market reforms. Almost a year into his term, the impact is starting to become evident. The World Bank says his policies will likely bring in some “$10 billion in net international reserves by the end of 2024.” Investors have taken notice. The Global X MSCI Argentina ETF (ARCA: ARGT) is up about 44% since Milei took office. Milei’s policies have helped to make him quite popular, and executives at Gaucho Group Holdings, Inc. (NASDAQ: VINO) believe all of this could increase opportunities for investors seeking to participate in the country’s expected growth. Gaucho Group Holdings Expanding In Argentina Gaucho Holdings is a diversified real estate and luxury brand holding company with assets in hospitality, wine making and fashion. The company also operates a growing collection of e-commerce platforms focused on fine wines, luxury real estate and leather goods and accessories. In May, Gaucho Holdings announced a new mortgage lending division intended to serve as the company’s self-financing option for buyers of its luxury vineyard real estate project, Algodon Wine Estates. Gaucho Holdings says it plans to expand the unit beyond its own properties in a move targeted to benefit from the Argentine government’s recent tax amnesty program. The program seeks to repatriate some $204 billion in untaxed wealth held by Argentinians outside the country. The company believes the tax amnesty measures could create an improved investment environment and a revival in mortgage lending. It says it believes the move could invite heightened confidence among Argentine citizens and the global investment community. The company argues that the Argentine real estate market is “now more promising than ever, as real estate values across the country reflect growing stability and demand.” Argentina’s Economic Landscape Is Evolving For many analysts, Argentina appears to be entering a new era of optimism. In his 2025 draft budget proposal, Milei estimates that his administration’s economic reforms will expand the economy by 5% in 2025. Banco Bilbao Vizcaya Argentaria (BBVA) (NYSE: BBVA) expects a 6% rebound in 2025. BBVA also expects the country’s GDP to grow by 4.5% in 2026 and to see inflation decline by nearly 38%. Since Milei became president, monthly inflation has dropped rapidly and recently hit a 31-month low, Gaucho Holdings reports. According to Doug Casey, a leading advisor to Gaucho Holdings, “If Milei’s reforms stick, within a decade, Argentina could become the most prosperous country in the world.” He attributes this to what he says is Argentina’s potential for substantial economic renewal, which he says has set the foundation for long-term growth and increasing the appeal for business travel and investment. In October, the World Bank announced over $2 billion in new loans to Argentina. About the same time, Argentina’s Central Bank said that it was working with banks and credit card companies to enable debit cards denominated in U.S. dollars. The move is part of the government’s push to adopt the U.S. dollar as Argentina’s official currency. Also in October, the Inter-American Development Bank (IDB) announced that it would grant $3.8 billion in aid to the country to be used for both public and private sector projects. Ilan Goldfajn, president of the IDB said that Milei’s reforms had “achieved remarkable progress in restoring much needed fiscal balance” to Argentina’s economy. Milei announced the country’s first quarterly budget surplus in 16 years in April. The changing economic landscape has prompted Argentina’s leading private bank, Grupo Financiero Galicia, to foresee a surge in lending. It expects new business and consumer loans to make up 40% of its total assets by the end of this year. Economic Reforms May Benefit Gaucho Holdings One possible sign that President Milei’s reforms are reshaping Argentina’s economy is that rental supply in Buenos Aires has surged since deregulation. And Gaucho Holdings says the promising signs of sustainable growth like this align with its strategic vision. The company believes such reforms may help reinforce its position across luxury real estate, hospitality, and fashion markets – each of which it expects to benefit from what it calls Argentina’s economic revival. Gaucho Holdings says that it is establishing itself as the “premier vehicle for investment in Argentina.” The company’s recent announcement said it is creating “a distinctive gateway for global investors who seek to participate in and benefit from Argentina's economic resurgence.” The company notes that its assets are strategically aligned with the country's “advancing market dynamics.” For Gaucho Holdings, capital infusions from the World Bank and the IDB enhance Argentina’s investment landscape and support the company’s growth initiatives in real estate, wine and luxury markets. It notes that stability attracts global interest. The company also says that deregulated markets enhance investment opportunities, and that the latest reforms facilitate smoother transactions and “enhance investor confidence.” The revival in consumer credit and home financing strengthens the market outlook, which could support Gaucho Holdings’ initiatives in real estate and position it to benefit from Argentina’s strengthened economic landscape, the company argues. It points out that real estate values in Argentina’s prime wine regions continue to offer substantial discounts per square foot compared to the world’s leading wine centers. Gaucho Holdings believes this presents an “unmatched opportunity” for growth. To align its commitment to promote Argentina’s growth and to connect with international investors, Gaucho Holdings recently hosted an exclusive wine tasting event in partnership with the Argentine Consulate in New York City. The event featured the latest releases of Malbec varietals from Algodon Fine Wines and was a platform for discussions about Argentina’s economic potential and the avenues for growth that international investment can support. Featured photo of Algodon Wine Estates in San Rafael, Mendoza, Argentina, courtesy of Gaucho Group Holdings, Inc. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

November 05, 2024 08:35 AM Eastern Standard Time

Image

SBC Medical Group (Nasdaq: SBC) CEO: "If We Become No. 1 In Asia, I Believe We Will Become No. 1 In The World"

Benzinga

By Gerelyn Terzo, Benzinga In what social media has declared the “undetectable era” of cosmetic surgery, beauty treatments have never been so appealing. As celebrities such as Christina Aguilera remain transparent about their cosmetic treatments while continuing to turn back the clock on their natural appearance, some experts say any stigma that was once associated with plastic surgery has disappeared. One leader from Asia now making its mark in the industry globally is SBC Medical Group Holdings (NASDAQ: SBC), a Tokyo-based medical company providing franchise services to aesthetic medical clinics and improving the lives of people around the world. In a recently aired webcast, SBC Medical CEO Yoshiyuki Aikawa shared his vision for the future of his growing company while also highlighting investment opportunities now that the stock is trading on the Nasdaq. He also explained that while the company has come so far, there is still more work to be done. Wall Street also seems to have paid attention. In a report released on Oct. 23, Zacks Small-Cap Research placed a $15.40 price target on SBC shares, suggesting the stock has room to almost double in price from its price of $7.23 at the time of the report’s publication. Zacks analyst M. Marin shared her insight on SBC’s franchise model as the company continues to expand its global footprint both organically and through M&A. Investors who are inclined to share in this bullish outlook can keep track of the company’s latest developments here. SBC Medical’s Growth Strategy While SBC Medical only recently became a publicly traded company, it’s been around for over two decades, getting its start as Shonan Beauty Clinic (SBC) in Japan’s Fujisawa city. Fast-forward, and SBC has evolved into a medical provider powerhouse, boasting the biggest network of franchised clinics in Japan and leading the country’s aesthetic medical industry as the Asia population boom continues to unfold. SBC Medical reports that it oversees 220 clinics, including Shoan Beauty clinics, and is growing, reaching close to 4 million customers each year – 70% of whom are repeat patients. Additionally, SBC Medical is in the early stages of international expansion, with clinics located in Los Angeles, CA. and Ho Chi Minh City, Vietnam. With its sights set on further expansion into adjacent fields, including B2B partnerships, SBC Medical, in many ways, is just getting started. “If we become No. 1 in Asia, I believe we will become No. 1 in the world,” said Mr. Aikawa. Chief among the services SBC Medical provides to aesthetic clinics are marketing services, but SBC also supports them in other ways such as recruitment, training, evaluations, medical equipment and expertise. Mr. Aikawa expects these facilities will serve as a springboard to debut additional clinics in these jurisdictions. SBC Medical’s management team represents nearly 25 years of experience in this industry, setting itself apart from the pack with features like a fully digitized integrated system and simplifying things for medical professionals. Its approach seems to be working, as SBC Medical reports that it holds the largest piece of the market share pie in Japan’s medical aesthetic sector, controlling close to one-third of the nation’s growing aesthetic medical segment and further solidifying its leadership position as a franchisor. SBC Medical’s Balance Sheet Mr. Aikawa, who has long been impressed by the effectiveness of aesthetic medicine, pointed to SBC Medical’s solid fundamentals on the balance sheet – the company is generating rising revenue that reached $194 million as of FY2023, coupled with an attractive profit margin. Its diversified portfolio also extends to other self-pay medical treatment areas such as fertility, orthopedic, regenerative medicine and laser eyecare, all of which appeal to many investors. Here’s a snapshot of the company’s financial strength: Revenue YoY Grow: A five-year compound annual growth rate (CAGR) of 24% Gross Profit Margin: 71%-plus Operating Profit Margin: 26%-plus Mr. Aikawa – a visionary whose passion for this business has proven unwavering – has made it his mission for SBC Medical to win. He prioritizes cash on the balance sheet that can be used for growth activities such as M&A. This stable balance sheet would also provide assurance for the sensitive needs of the medical practices that SBC supports. He also has strong hopes for the company’s convenient, trustworthy and efficient online clinical services, including services like AI med provided by the group company, the performance of which has been growing annually. Japan’s Aesthetic Medical Market Growth Potential Japan is a major focus area for SBC Medical, considering only 10% of the country’s population currently seeks aesthetic medical treatments, a low base with enormous potential. Mr. Aikawa expects that segment to at least double to 20% to be closer in line with South Korea’s population turning to cosmetic surgery, owing in part to the advertising campaigns of the Shonan Beauty Clinic. Market penetration among Japan’s core customer group – women up to their 30s – is growing. However, the sweet spot for SBC Medical here is both middle-aged male and female markets, as SBC Medical pursues affordable price points that will make monthly clinic visits possible. “I feel like we are only halfway through achieving that goal, so we should work even harder,” said Mr. Aikawa, pointing out that the number of customers aged 40 is increasing. As SBC Medical continues to expand its clinical base and improve the lives of people around the world, interested investors have an opportunity to participate in its growth story. Zacks’ analyst research suggests SBC Medical has the wind at its back, particularly owing to an increasingly popular aesthetics medicine market in Japan. Investors can learn more about SBC Medical’s stock and fundamentals here. Featured photo by Alexas_Fotos on Pixabay. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

November 05, 2024 08:30 AM Eastern Standard Time

Image

News Release

Building Momentum: Zynex Inc.’s (NASDAQ: ZYXI) Steady Rise in the Pain Management Market

ZYXI

Demand for pain management devices is climbing worldwide, fueled by several major trends. As chronic disease rates soar, the need for effective, drug-free pain solutions has grown more pressing. At the same time, advancements in medical tech have opened doors to safer, non-invasive pain relief options, making them more widely adopted by healthcare providers. Rising numbers of surgeries have also created a strong demand for post-operative pain control, while the pain monitoring market continues to surge. With these combined factors, the global pain management device market is expected to reach $5.68 billion by 2032, expanding at a steady 9% CAGR. In this dynamic and fast-evolving field, Zynex Inc. (NASDAQ: ZYXI) stands out as a key player, bringing new solutions to the growing pain management market. A Closer Look at a Leading Innovator in Pain Management Founded in 1996, Zynex Inc. has carved out a unique space in the medical technology industry, specializing in non-invasive medical devices designed for pain management and rehabilitation. With a mission to improve the lives of patients with chronic pain and other debilitating conditions, Zynex consistently develops innovative solutions that support pain management without relying on medications. The recent FDA approval of its latest device, the TensWave, and strong financial performance through Q3 2024 highlight Zynex’s upward trajectory in a growing market. Expanding Product Line with FDA-Cleared TensWave Device Zynex's newest offering, the TensWave device, received FDA clearance in September 2024. This device is a non-invasive pain relief option that uses TENS (Transcutaneous Electrical Nerve Stimulation) technology, a proven method to alleviate pain without medication. According to CEO Thomas Sandgaard, TensWave was developed to meet the demand for a high-quality TENS device that fits insurance reimbursement criteria. "We recognized a gap in the market," Sandgaard said, "and TensWave is our answer to that demand. It complements our flagship device, the NexWave, by giving patients a safe, effective, and drug-free alternative for pain relief." The TensWave device is designed to work in tandem with Zynex’s other products, specifically the NexWave, which offers multiple electrotherapy modalities. While NexWave remains Zynex’s top-tier product, TensWave offers a more targeted solution for patients covered under insurance plans that only reimburse TENS-based treatments. By diversifying its product lineup, Zynex positions itself to cater to a broader range of insurance plans, potentially reaching more patients who need accessible and effective pain management tools. Strong Financial Performance and Business Growth Zynex’s Q3 2024 financial results showcase the company’s resilience and growth momentum. During the quarter, orders in the Pain Management division saw a 13% increase compared to the same period in 2023, while revenue per sales representative jumped by 25%, reaching approximately $530,000. Overall, Zynex reported net revenue of $50 million, a slight increase from the previous year, and net income of $2.4 million, equating to an EPS of $0.07. Cash flow from operations was robust at $7.1 million, and the company’s working capital stood at $58.5 million as of September 30, 2024. In February 2022, an article from Seeking Alpha suggested that Zynex might face a 50% drop in EBITDA due to contract changes with UnitedHealthcare. However, rather than the anticipated loss, Zynex managed to maintain and even grow its partnership with UnitedHealthcare. Over the past three years, Zynex has consistently added new patients with UnitedHealthcare, backed by a renewed agreement with the insurer. Notably, Zynex has recorded steady revenue growth, with year-over-year increases of 21%, 17%, and 9% since 2022, effectively countering these earlier predictions and showcasing Zynex’s operational strength. Looking ahead to Q4, Zynex has set a revenue target of $53.6 million with an estimated EPS of $0.09. For the full year of 2024, the company expects to achieve net revenue of at least $200 million, representing a 9% growth from the prior year and an EPS of $0.20. These projections suggest that Zynex is on track to sustain its current pace of expansion. Strategic Focus on Innovation and Market Adaptability One of Zynex’s core strengths lies in its ongoing commitment to research and development, aiming to diversify its product portfolio to address unmet needs in pain management. Sandgaard has emphasized that Zynex’s long-term goals include not just incremental growth in its pain management division but also the expansion of its orthopedic products, ensuring that the company has a well-rounded suite of medical devices. In the words of Sandgaard, “We are working to expedite the onboarding of new sales reps while maintaining a high standard for productivity. Our focus on FDA approvals of next-generation devices and new therapy products delivered FDA clearance of our new TensWave device during the quarter.” Alongside pain management, Zynex is making strides in non-invasive monitoring systems for hospital use, indicating that the company is serious about diversifying beyond its core offerings. This multi-pronged approach gives Zynex the flexibility to adjust to changing market demands while further establishing its reputation as a provider of comprehensive, non-invasive healthcare solutions. Future Growth Potential With the FDA approval of the TensWave device, Zynex has reinforced its presence in the pain management market, where demand for non-opioid treatment options is on the rise. The device could become a significant revenue driver, particularly as the opioid crisis has heightened interest in alternative pain management therapies. TENS therapy, a proven method for reducing both chronic and acute pain, positions Zynex favorably among patients and healthcare providers looking for safe, effective treatments. Zynex’s current product line also includes devices for cold and hot therapy, cervical traction, braces, and compression solutions, allowing it to cater to a broad array of patient needs. As the company anticipates a return to its typical growth rate of approximately 20% in the pain management division in 2025, the new products and strong sales infrastructure could enable it to scale more effectively. Conclusion In 2024, Zynex Inc. (NASDAQ: ZYXI) has shown resilience by expanding its product portfolio and maintaining steady growth. The FDA clearance of the TensWave device further strengthens its position in the non-invasive pain management field, supporting its mission to deliver effective, drug-free pain solutions. With solid revenue growth and strong partnerships, ZYXI is set to build on its progress, providing lasting value for patients and shareholders alike. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performances are not statements of historical fact and may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Awareness Consulting to assist in the production and distribution of this content. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only; you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third-party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Mark McKelvie +1 585-301-7700 mark@razorpitch.com Company Website http://razorpitch.com

November 05, 2024 07:00 AM Eastern Standard Time

1 ... 31 32 33 34 35 ... 3787